Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia
Sujit Suklabaidya, Biswajit Das, Syed Azmal Ali, et al.
Oncotarget (2016) Vol. 7, Iss. 27, pp. 41825-41842
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Pirfenidone normalizes the tumor microenvironment to improve chemotherapy
Christiana Polydorou, Fotios Mpekris, Panagiotis Papageorgis, et al.
Oncotarget (2017) Vol. 8, Iss. 15, pp. 24506-24517
Open Access | Times Cited: 160
Pancreatic cancer: Stroma and its current and emerging targeted therapies
Janaiah Kota, Julie Hancock, Jason J. Kwon, et al.
Cancer Letters (2017) Vol. 391, pp. 38-49
Closed Access | Times Cited: 157
Targeting Pancreatic Stellate Cells in Cancer
Jonas Schnittert, Ruchi Bansal, Jai Prakash
Trends in cancer (2019) Vol. 5, Iss. 2, pp. 128-142
Open Access | Times Cited: 118
The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment
Kelly J. Lafaro, Laleh G. Melstrom
American Journal Of Pathology (2018) Vol. 189, Iss. 1, pp. 44-57
Open Access | Times Cited: 73
Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer
P. Ramakrishnan, Wei Mee Loh, Subash C. B. Gopinath, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 3, pp. 399-413
Open Access | Times Cited: 71
The pancreatic cancer microenvironment: A true double agent
Laleh G. Melstrom, Marcela D Salazar, Don J. Diamond
Journal of Surgical Oncology (2017) Vol. 116, Iss. 1, pp. 7-15
Open Access | Times Cited: 65
The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
Yang Wu, Chun Zhang, Kuirong Jiang, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 54
Experimental models of pancreatic cancer desmoplasia
Sujit Suklabaidya, Pujarini Dash, Biswajit Das, et al.
Laboratory Investigation (2017) Vol. 98, Iss. 1, pp. 27-40
Open Access | Times Cited: 58
Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies
Voddu Suresh, Deepti Parida, Aliva Prity Minz, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 39
The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β
Gang Wang, Xiaowan Zhou, Zengli Guo, et al.
Cancer Biology & Therapy (2022) Vol. 23, Iss. 1, pp. 150-162
Open Access | Times Cited: 28
Relaxin-expressing oncolytic adenovirus induces remodeling of physical and immunological aspects of cold tumor to potentiate PD-1 blockade
Bo‐Kyeong Jung, Hae Young Ko, Hyunji Kang, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000763-e000763
Open Access | Times Cited: 39
Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
Laura De Lellis, Serena Veschi, Nicola Tinari, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 3946-3946
Open Access | Times Cited: 30
Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy
Yangyang Jia, Yanru Wang, Louisa S. Chard, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo
Bo Cheng, Qiaofang Wang, Yaodong Song, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 30
Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control
Dafne C.A. Quixabeira, Sadia Zafar, João M. Santos, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 27
The Role of Desmoplasia and Stromal Fibroblasts on Anti-cancer Drug Resistance in a Microengineered Tumor Model
Harpinder Saini, Kiarash Rahmani Eliato, Casey Silva, et al.
Cellular and Molecular Bioengineering (2018) Vol. 11, Iss. 5, pp. 419-433
Open Access | Times Cited: 32
Shattering the castle walls: Anti-stromal therapy for pancreatic cancer
Özkan Kanat, Hülya Ertaş
World Journal of Gastrointestinal Oncology (2018) Vol. 10, Iss. 8, pp. 202-210
Open Access | Times Cited: 31
Desmoplasia and Biophysics in Pancreatic Ductal Adenocarcinoma
Francesco Di Maggio, Karim El-Shakankery
Pancreas (2020) Vol. 49, Iss. 3, pp. 313-325
Closed Access | Times Cited: 25
Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome
Aliva Prity Minz, Debasish Mohapatra, Madhuri Dutta, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 4261-4278
Open Access | Times Cited: 8
N-acetyl cysteine induces quiescent-like pancreatic stellate cells from an active state and attenuates cancer-stroma interactions
Haimin Feng, Taiki Moriyama, Kenoki Ohuchida, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 17
Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells
Biswajit Das, Shantibhusan Senapati
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 18
Leveraging cellular mechano-responsiveness for cancer therapy
Jeongeun Hyun, Hae‐Won Kim
Trends in Molecular Medicine (2021) Vol. 28, Iss. 2, pp. 155-169
Closed Access | Times Cited: 12
Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis
Debasish Mohapatra, Biswajit Das, Voddu Suresh, et al.
Laboratory Investigation (2021) Vol. 102, Iss. 3, pp. 298-311
Open Access | Times Cited: 11
Macrophage migration inhibitory factor of Syrian golden hamster shares structural and functional similarity with human counterpart and promotes pancreatic cancer
Voddu Suresh, Rajivgandhi Sundaram, Pujarini Dash, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 9
MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway‐induced p53‐dependent apoptosis
Voddu Suresh, Pujarini Dash, Sujit Suklabaidya, et al.
The FASEB Journal (2022) Vol. 36, Iss. 8
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top